Key facts
- This page summarizes David J. Brailer's Form 4 filing for Cigna Group (CI).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Mar 2025, 19:52.
David J. Brailer - 28 Feb 2025 Form 4 Insider Report for Cigna Group (CI)
- Reporting relationship
- EVP & Chief Health Officer
- Issuer ticker
- CI
- Reported as of
- 28 Feb 2025
- Net transaction value
- -$1,042,065
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2025, 19:52:21 UTC
- Prior SEC filing
- 04 Sep 2024
- Next SEC filing
- 03 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- Matthew Arnold, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David J. Brailer filed Form 4 for Cigna Group (CI) on 04 Mar 2025.
Change
- Previous filing in this sequence was filed on 04 Sep 2024.
- Current net transaction value: -$1,042,065.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CI
transaction
Common Stock, $.01 Par Value
Award
- Transaction value
- $0
- Shares
- +6,540
- Change %
- +72%
- Price
- $0.000000
- Shares after
- 15,582
- Date
- 28 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
CI
transaction
Common Stock, $.01 Par Value
Award
- Transaction value
- $0
- Shares
- +5,640
- Change %
- +36%
- Price
- $0.000000
- Shares after
- 21,222
- Date
- 28 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
CI
transaction
Common Stock, $.01 Par Value
Tax liability
- Transaction value
- $237,042
- Shares
- -775
- Change %
- -3.7%
- Price
- $305.86
- Shares after
- 20,447
- Date
- 28 Feb 2025
- Ownership
- Direct
- Footnotes
- F3
CI
transaction
Common Stock, $.01 Par Value
Tax liability
- Transaction value
- $805,024
- Shares
- -2,632
- Change %
- -13%
- Price
- $305.86
- Shares after
- 17,815
- Date
- 28 Feb 2025
- Ownership
- Direct
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CI
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +23,222
- Change %
- Price
- $0.000000
- Shares after
- 23,222
- Date
- 28 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 23,222
- Exercise price
- $305.86
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
These restricted shares vest in full on March 1, 2026.
Footnote F2
The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
Footnote F3
Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
Footnote F4
Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
Footnote F5
This option vests in full on March 1, 2026.
SEC remarks
Exhibit List: EX-24 Power of Attorney poabrailer.txt